XBRU
AZE
Market cap2.74bUSD
Jun 18, Last price
9.80EUR
1D
-2.29%
1Q
41.01%
IPO
-64.23%
Name
Azelis Group NV
Chart & Performance
P/E
13.21
P/S
0.56
EPS
0.74
Div Yield, %
2.35%
Shrs. gr., 5y
0.84%
Rev. gr., 5y
15.13%
Revenues
4.13b
-2.49%
Net income
111m
-38.46%
CFO
311m
-3.71%
Dividend
Jun 29, 20260.1582 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Azelis Group NV functions as a global distributor, supplying specialized chemicals and food ingredients. The company's operations extend across a diverse range of life science sectors, including personal care, pharmaceuticals, food and wellness products, specialized agricultural and horticultural solutions, and both homecare and industrial chemicals. Furthermore, Azelis provides materials for the industrial chemicals industry, encompassing applications like CASE (Coatings, Adhesives, Sealants, Elastomers), rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper. Established in 1996, Azelis Group NV is headquartered in Antwerp, Belgium, and operates as a subsidiary of Akita I S.À R.L.
IPO date
Sep 17, 2021
Employees
3,800
Domiciled in
BE
Incorporated in
BE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||